Any pressure on INR likely to be confined to short run, given the robust fundamentals and comfortable current account situation, notes RBI minutes
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
30 minutes ago
- Time of India
India pharma, healthcare revenue to grow steadily in Q1FY26E; EBITDA margins under pressure: Report
Indian pharma and healthcare sector will witness steady revenue growth in the first quarter of the Financial Year 2026 (Q1FY26E), but concerns loom as EBITDA margins are expected to decline amid rising input costs and pricing pressures, according to a report by HDFC Securities. The report added that the pharma sector firms studied by it may witness a 11 per cent year-on-year (YoY) sales growth, driven by an 11 per cent YoY increase in the India business along with 2 per cent QoQ growth in US sales (+2 per cent YoY). The EBITDA, which stands for Earnings Before Interest, Taxes, Depreciation, and Amortization, is a financial metric used to assess a company's profitability and operational efficiency. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like 이 게임은 대부분의 TV 프로그램보다 더 재미있어요 – 게다가 무료예요. Raid: Shadow Legends 플레이하기 Undo The report stated that EBITDA margins for the pharma segment are expected to decrease by 42bps YoY, driven by price erosion in the US and an expected increase in research and development (R&D). The hospital business is projected to grow by 15 per cent YoY, as muted occupancy will be partly supported by steady ARPOB, or Average Revenue Per Occupied Bed, which is a key performance indicator used in the healthcare industry to assess a hospital's financial performance. Live Events India's pharmaceutical market for FY 2023-24 is valued at USD 50 billion, with domestic consumption valued at USD 23.5 billion and exports valued at USD 26.5 billion. The domestic pharma industry is considered to be the world's third-largest by volume and 14th in terms of value of production. With an extremely diversified product base covering generic drugs, bulk drugs, over-the-counter drugs, vaccines, biosimilars, and biologics, the Indian pharmaceutical industry has a strong presence at the global level. According to National Accounts Statistics 2024, published by the Ministry of Statistics and Programme Implementation, total output for industry, i.e., Pharmaceuticals, medicinal and botanical products, is Rs. 4,56,246 crores for FY 2022-23 at constant prices, of which value added is Rs 1,75,583 crores.
India.com
42 minutes ago
- India.com
Meet Man Who Left Goldman Sachs To Become Security Guard, Later Joined An IAF Pilot to Build Rs 16,70,00,00,000 Company — Know Who He Is...
photoDetails english 2930652 MyGate Success Story: Industrialist Harsh Goenka recently shared the amazing story of Abhishek Kumar, an IIT Kanpur graduate who gave up a high-paying job to become a security guard. But this was no ordinary job switch. Abhishek worked 14-hour shifts in uniform to deeply understand how security works in Indian gated communities. People thought he was just another guard. No one knew he was actually building something big—MyGate. Today, MyGate is used by over 4 million people in 25,000 housing societies. It handles more than 100 million check-ins every month and has helped 1.2 million security guards switch to digital tools. Abhishek didn't do this alone. He teamed up with Vijay Arisetty, a former pilot and war veteran, and Shreyansh Daga, a tech expert from IIT-Guwahati and ISB. With their combined knowledge from top Indian institutions, the trio turned a simple idea into one of India's leading community apps. From guarding gates to guarding homes with smart tech—MyGate has changed the way India lives. Updated:Jul 12, 2025, 12:37 PM IST From Goldman Sachs To Guard Duty 1 / 8 Abhishek Kumar, an IIT Kanpur alumnus and former Goldman Sachs executive, took up 14-hour shifts as a security guard. His goal wasn't employment—it was deep, firsthand research into the problems faced by security staff at gated communities. Abhishek Kumar- A Actual Security Guard 2 / 8 Residents believed Abhishek Kumar was an actual guard. His research was so immersive that no one suspected he was on a mission to disrupt the security ecosystem and later lead India's top gated community management app—MyGate. Founding Of MyGate In 2016 3 / 8 In 2016, Abhishek Kumar teamed up with Vijay Arisetty, a former Indian Air Force (IAF) pilot who received the Shaurya Chakra for saving hundreds of lives in Andaman & Nicobar Islands in the 2004 tsunami, and Shreyansh Daga to launch MyGate—a platform designed to manage visitor entry, maintenance, housekeeping, and security services in Indian housing societies using smart, digital solutions. MyGate: Reaching Millions of Homes 4 / 8 Today, MyGate is trusted by over 4 million residents across 25,000 housing communities. The platform handles more than 100 million digital check-ins each month, ensuring streamlined and secure access for visitors and service providers. MyGate: Rs 100 Crore Funding Boost 5 / 8 In 2022, MyGate secured ₹100 crore in a funding round led by Urban Company and Acko. The funding supported the platform's growth, innovation, and expansion into new areas like home automation and smart security. MyGate: Launch of Smart Locks in 2023 6 / 8 In September 2023, MyGate stepped into the smart home segment with 'MyGate Locks'—a range of smart door locks aimed at enhancing digital security for Indian households, further expanding the company's product portfolio and impact. Strong Financial Turnaround 7 / 8 MyGate's revenue jumped from ₹77 crore in FY23 to ₹109 crore in FY24. Impressively, its net losses also reduced drastically from ₹227 crore to just ₹39.7 crore, showing improved operational efficiency and growth. Abhishek kumar's MygGate Valuation Milestone 8 / 8 The three co-founders—Kumar, Arisetty, and Daga—now hold a combined 24.83% stake in MyGate. The company is currently valued at Rs 1,670 crore (around $200 million), according to startup data platform Tracxn.
India Gazette
44 minutes ago
- India Gazette
JP Nadda meets Saudi-India Business Council Chief, highlights investment opportunities in India
Dammam [Saudi Arabia], July 12 (ANI): Union Health Minister and BJP National President JP Nadda engaged with the Chairman of the Saudi-India Business Council, Abdulaziz Al Qahtani, along with the business community in Dammam in the country's Eastern Province, with discussions on the expansion of the economic partnership between India and Saudi Arabia. In a post on X, Nadda stated that he had a 'fruitful meeting' with Al Qahtani and held an in-depth discussion on the growing economic partnership and increasing collaboration between companies from both nations. The Union Minister also highlighted the vast investment opportunities in India across sectors such as fertilisers, chemicals, and pharmaceuticals, encouraging Saudi businesses to participate actively in India's growth journey. 'Had a fruitful meeting with Mr. Abdulaziz Al Qahtani, Chairman of the Saudi-India Business Council, and engaged with key members of the vibrant business community in Dammam, Eastern Province. We had in-depth discussions on the growing economic partnership between India and Saudi Arabia, and the increasing collaboration between companies from both nations. Highlighted the vast investment opportunities available across diverse sectors in India--including fertilisers, chemicals, pharmaceuticals, and more--and encouraged Saudi businesses to actively participate in India's growth journey,' Nadda stated in the post. Nadda is currently on an official visit to the Kingdom and is accompanied by senior officers and representatives of a number of fertiliser companies. 'Hon'ble Minister of Chemicals & Fertilisers and Health & Family Welfare, Shri JP Nadda, arrived in Saudi Arabia on an official visit. He was received at the King Fahad International Airport, Dammam, by Ambassador Dr Suhel Ajaz Khan. Hon'ble Minister is accompanied by senior officers and representatives of a number of fertiliser companies,' the Embassy of India in Riyadh stated in a post on X. According to the Ministry of External Affairs, in Economic Cooperation, India is the second-largest trade partner of Saudi Arabia, whereas Saudi Arabia is the fourth-largest trading partner of India. During FY23, bilateral trade was valued at USD 52.76 billion. During this period, India's imports from Saudi Arabia grew by 23.47 per cent to reach USD 42.03 billion, and exports to Saudi Arabia were worth USD 10.72 billion, registering an increase of 22.48 per cent on a year-on-year basis. Total trade with Saudi Arabia accounted for 4.53 per cent of India's total trade in FY 2022-23. There are around 2,783 Indian companies registered as joint ventures or 100 per cent owned entities with investments worth approximately USD 2 billion in the Kingdom as of January 2022, as per the MEA. Saudi Arabia's direct investments in India amount to USD 3.15 billion as of March 2022. In June 2020, Saudi Arabia's Public Investment Fund (PIF) announced a USD 1.49 billion or a 2.32 per cent stake investment in Reliance Industries' Jio Platforms. In November 2020, PIF announced another investment of USD 1.3 billion or a 2.04 per cent stake in Reliance Retail Ventures Limited. In addition to this, there are also projects under consideration in the oil, gas and petroleum sectors. In the renewable energy sector, Saudi Company Al-Fanar has invested in a 600MW Wind Power project in India, as per the MEA. (ANI)
